BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases - PubMed (original) (raw)

. 2002 Oct 15;169(8):4314-21.

doi: 10.4049/jimmunol.169.8.4314.

Svetlana Sosnovtseva, Christopher D Ward, June S Hong, Rodger Smith, Vivian Albert, William Stohl, Kevin P Baker, Stephen Ullrich, Bernardetta Nardelli, David M Hilbert, Thi-Sau Migone

Affiliations

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

Viktor Roschke et al. J Immunol. 2002.

Abstract

BLyS and APRIL are two members of the TNF superfamily that are secreted by activated myeloid cells and have costimulatory activity on B cells. BLyS and APRIL share two receptors, TACI and BCMA, whereas a third receptor, BAFF-R, specifically binds BLyS. Both BLyS and APRIL have been described as homotrimeric molecules, a feature common to members of the TNF superfamily. In this study, we show that APRIL and BLyS can form active heterotrimeric molecules when coexpressed and that circulating heterotrimers are present in serum samples from patients with systemic immune-based rheumatic diseases. These findings raise the possibility that active BLyS/APRIL heterotrimers may play a role in rheumatic and other autoimmune diseases and that other members of the TNF ligand superfamily may also form active soluble heterotrimers.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources